DocSym
β
Searchsearch
Search
(A44.1) Cutaneous and mucocutaneous bartonellosis
More details coming soon
5 146 in individuals diagnosis cutaneous and mucocutaneous bartonellosis confirmed
Diagnosis cutaneous and mucocutaneous bartonellosis is diagnosed Women are 23.47% more likely than Men
1 969
Men receive the diagnosis cutaneous and mucocutaneous bartonellosis
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
3 177
Women receive the diagnosis cutaneous and mucocutaneous bartonellosis
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease cutaneous and mucocutaneous bartonellosis - Men aged 15-19 and Women aged 75-79
In Men diagnosis is most often set at age 0-5, 10-19, 45-69
Less common in men the disease occurs at Age 0-1, 5-9, 20-44, 70-95+Less common in women the disease occurs at Age 0-5, 25-34, 45-49, 60-64, 70-74, 85-95+
In Women diagnosis is most often set at age 0-1, 5-24, 35-44, 50-59, 65-69, 75-84
Disease Features cutaneous and mucocutaneous bartonellosis
Absence or low individual and public risk
Cutaneous and mucocutaneous bartonellosis - what does this mean
Cutaneous and mucocutaneous bartonellosis is a bacterial infection caused by the bartonella species of bacteria. it is spread by the bite of fleas, lice, and other arthropods, and can cause skin lesions, fever, and lymph node enlargement. it can also affect the mucous membranes of the eyes, nose, mouth, and throat.
What happens during the disease - cutaneous and mucocutaneous bartonellosis
Cutaneous and mucocutaneous bartonellosis is an infection caused by the bacteria bartonella henselae. it is typically spread through contact with infected cats, fleas, or flea feces. the bacteria enters the body through broken skin or mucous membranes and causes inflammation and swelling of the skin. it can also cause fever, headache, and fatigue. in some cases, the infection can spread to the lymph nodes, liver, and spleen, leading to more serious complications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination and history taking
- Laboratory tests such as blood cultures, serology, and PCR
- Skin biopsy
- Imaging tests such as X-ray, ultrasound, or CT scan
- Tissue culture
- Treatment with antibiotics
Treatment and Medical Assistance
Main goal of the treatment: To reduce the severity and duration of symptoms of cutaneous and mucocutaneous bartonellosis.
- Administering antibiotics to combat the infection
- Prescribing topical creams to reduce inflammation
- Encouraging proper hygiene to prevent recurrence of the infection
- Prescribing oral antihistamines to reduce itching
- Prescribing oral steroids to reduce swelling
- Prescribing oral antifungal medications to reduce fungal overgrowth
- Prescribing topical antifungal medications to reduce fungal overgrowth
- Prescribing topical antibiotics to reduce bacterial overgrowth
- Prescribing oral antiviral medications to reduce viral overgrowth
- Prescribing topical antiviral medications to reduce viral overgrowth
- Encouraging adequate rest and nutrition to support immune system
- Encouraging stress reduction activities to reduce the severity of symptoms
18 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Cutaneous and mucocutaneous bartonellosis - Prevention
Cutaneous and mucocutaneous bartonellosis is best prevented by avoiding contact with infected animals, particularly cats, and taking precautions when handling them such as wearing gloves and washing hands afterwards. additionally, avoiding contact with soil and sand that may be contaminated with the causative bacteria is also recommended.